newsfilter
← Latest News
PR Newswire·

Intensity Therapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

Intensity Therapeutics, Inc. (Nasdaq: INTS) ("Intensity" or "the Company"), a late-stage clinical biotechnology company focused on the discovery and...